v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net (loss) income $ (136) $ 819
Reconciliations of net (loss) income to net cash provided by (used in) operating activities:    
Depreciation and amortization 1,852 1,677
Non-cash lease expense 1,711 1,756
Net investment (accretion) amortization (396) 237
Share-based compensation 2,187 1,928
Changes in certain operating assets and liabilities:    
Trade accounts receivable (28,961) (24,175)
Income taxes 260 112
Prepaid expenses and other (70) (818)
Accounts payable (896) (2,880)
Accrued payroll, payroll taxes and related benefits 22,048 13,944
Other accrued liabilities (3,135) (1,224)
Premium payable 26,167 (1,413)
Workers' compensation claims liabilities (9,835) (14,412)
Operating lease liabilities (1,806) (1,819)
Other assets and liabilities, net (11) (247)
Net cash provided by (used in) operating activities 8,979 (26,515)
Cash flows from investing activities:    
Purchase of property, equipment and software (2,779) (2,995)
Proceeds from sales and maturities of investments 8,290 233
Purchase of restricted investments (4,649) (1,725)
Proceeds from sales and maturities of restricted investments 13,253 2,446
Net cash provided by (used in) investing activities 14,115 (2,041)
Cash flows from financing activities:    
Repurchases of common stock (7,056) (8,030)
Common stock repurchased on vesting of stock awards (1,456) (1,005)
Dividends paid (1,970) (2,067)
Proceeds from exercise of stock options and purchase of ESPP 376 339
Net cash used in financing activities (10,106) (10,763)
Net increase (decrease) in cash, cash equivalents and restricted cash 12,988 (39,319)
Cash, cash equivalents and restricted cash, beginning of period 74,841 107,378
Cash, cash equivalents and restricted cash, end of period $ 87,829 $ 68,059

Source